ArticleLeukemia2025

High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease.

Denise Toscani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.